Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Shanker

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cancer Research|August 6, 2009
Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicityAnil Shanker, Alan D Brooks, Kristen M Jacobsen, et al.
Frontiers in Immunology|March 15, 2021
Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1Ariana N Renrick, Menaka C Thounaojam, Maria Teresa P de Aquino, et al.
Oncotarget|October 3, 2015
Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalkMenaka C Thounaojam, Duafalia F Dudimah, Samuel T Pellom, et al.
Journal of Biotechnology and Biomedicine|December 30, 2024
Enhancing Data Science and Genomics Capacity of a Historically Black Medical College Through Interdisciplinary Training and Research CollaborationsQingguo Wang, Vibhuti Gupta, Aize Cao, et al.
Cancers|February 10, 2024
Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRAS<sup>mut</sup>/P53<sup>mut</sup> Lung Cancer Cells by Inhibiting c-FLIPThanigaivelan Kanagasabai, Zerick Dunbar, Salvador González Ochoa, et al.
International Journal of Molecular Sciences|July 13, 2024
Loss of Mitochondrial Tusc2/Fus1 Triggers a Brain Pro-Inflammatory Microenvironment and Early Spatial Memory ImpairmentTonie Farris, Salvador González-Ochoa, Muna Mohammed, et al.
FEBS Open Bio|October 19, 2020
The rapid endocytic uptake of fetuin-A by adherent tumor cells is mediated by Toll-like receptor 4 (TLR4)Portia L Thomas, Gladys Nangami, Tanu Rana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibitionWilliam H D Hallett, Erik Ames, Milad Motarjemi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
CD8 T cell help for innate antitumor immunityAnil Shanker, Grégory Verdeil, Michel Buferne, et al.
Communications Medicine|August 25, 2023
Development of a decentralized cohort for studying post-acute sequelae of COVID-19 in India in the Data4life StudyJosh Schilling, Sepideh Shokouhi, Aisha Montgomery, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Research|August 6, 2009
Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicityAnil Shanker, Alan D Brooks, Kristen M Jacobsen, et al.
Frontiers in Immunology|March 15, 2021
Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1Ariana N Renrick, Menaka C Thounaojam, Maria Teresa P de Aquino, et al.
Oncotarget|October 3, 2015
Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalkMenaka C Thounaojam, Duafalia F Dudimah, Samuel T Pellom, et al.
Journal of Biotechnology and Biomedicine|December 30, 2024
Enhancing Data Science and Genomics Capacity of a Historically Black Medical College Through Interdisciplinary Training and Research CollaborationsQingguo Wang, Vibhuti Gupta, Aize Cao, et al.
Cancers|February 10, 2024
Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRAS<sup>mut</sup>/P53<sup>mut</sup> Lung Cancer Cells by Inhibiting c-FLIPThanigaivelan Kanagasabai, Zerick Dunbar, Salvador González Ochoa, et al.
International Journal of Molecular Sciences|July 13, 2024
Loss of Mitochondrial Tusc2/Fus1 Triggers a Brain Pro-Inflammatory Microenvironment and Early Spatial Memory ImpairmentTonie Farris, Salvador González-Ochoa, Muna Mohammed, et al.
FEBS Open Bio|October 19, 2020
The rapid endocytic uptake of fetuin-A by adherent tumor cells is mediated by Toll-like receptor 4 (TLR4)Portia L Thomas, Gladys Nangami, Tanu Rana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibitionWilliam H D Hallett, Erik Ames, Milad Motarjemi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
CD8 T cell help for innate antitumor immunityAnil Shanker, Grégory Verdeil, Michel Buferne, et al.
Communications Medicine|August 25, 2023
Development of a decentralized cohort for studying post-acute sequelae of COVID-19 in India in the Data4life StudyJosh Schilling, Sepideh Shokouhi, Aisha Montgomery, et al.
Pageof 7